Optical molecular imaging agents for cancer diagnostics and therapeutics

Nanomedicine

Volumn 1, Issue 1, 2006, Pages 23-30

  Kumar, Sonia ^a   Richards Kortum, Rebecca ^b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b RICE UNIVERSITY   (United States)

Author keywords

Cancer; Contrast agents; Diagnostics; Molecular markers; Optical imaging; Therapeutics

Indexed keywords

NANOPARTICLE; QUANTUM DOT;

CHEMISTRY; DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HUMAN; METHODOLOGY; NEOPLASM; OPTICS; REVIEW;

DIAGNOSTIC IMAGING; EARLY DIAGNOSIS; HUMANS; NANOPARTICLES; NEOPLASMS; OPTICS; QUANTUM DOTS;

EID: 34247324472     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/17435889.1.1.23     Document Type: Review

References (51)

1. Reid R: Genital warts and cervical cancer. Is human papillomavirus infection the trigger to cervical carcinogenesis? Gynecol. Oncol 15(2), 239-252 (1983).
2. Dürst M, Gissmann L, Ikenberg H, zur Hausen H: A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc. Natl Acad. Sci. USA 80(12), 3812-3815 (1983).
3. Frazer IH: Prevention of cervical cancer through papillomavirus vaccination. Nat. Rev. Immunol 4, 46-55 (2004).
4. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100(1), 57-70 (2000).
5. Tempany CMC, McNeil BJ: Advanced in biomedical imaging. JAMA 285(5), 562-567 (2001).
6. Ramanujam N: Fluorescence spectroscopy of neoplastic and non-neoplastic tissues. Neoplasia 2(1-2), 89-117 (2000).
7. Weiner LM: An overview of monoclonal antibody therapy of cancer. Semin. Oncol. 26(4 Suppl. 12), 41-50 (1999).
8. Smith GP, Petrenko VA: Phage display. Chem. Rev. 97, 391-410 (1997).
9. Marshall KA, Ellington AD: In vitro selection of RNA aptamers. Methods Enzymol 318, 193-214 (2000).
10. Brooks H, Lebleu B, Vives E: Tat peptide-mediated cellular delivery: back to basics. Adv. Drug Deliv. Rev. 57, 559-577 (2005).
11. Yguerabide J, Yguerabide EE: Resonant light scattering particles as ultrasensitive labels for detection of analytes in a wide range of applications, J. Cell Bio. 37(Suppl.), 71-81 (2001).
12. Mulvaney P: Surface plasmon spectroscopy of nanosized metal particles. Langmuir 12(3), 788-800 (1996).
13. Frens G: Controlled nucleation for the regulation of the particle size in monodisperse gold suspensions. Nat. Phys. Sci. 241, 20-22 (1973).
14. Horisberger M: Colloidal gold: a cytochemical marker for light and fluorescent microscopy and for transmission and scanning electron microscopy. Scan. Electron Microsc. 2, 9-31 (1981).
15. Geoghegan WD, Ackerman GA: Adsorption of horseradish peroxidase, ovomucoid and anti-immunoglobulin to colloidal gold for the indirect detection of concanavalin A, wheat germ agglutinin and goat anti-human immunoglobulin G on cell surfaces at the electron microscopic level: a new method, theory and application. J. Histochem. Cytochem. 25(11), 1187-1200(1977).
16. Reenberger W, Hohenau A, Leitner A, Krenn JR, Lamprecht B, Aussenegg FR: Optical properties of two interacting gold nanoparticles. Optics Commun. 220, 137-141 (2003).
17. Sönnichsen C, Reinhard BM, Liphardt J, Alivisatos AP: A molecular ruler based on plasmon coupling of single gold and silver nanoparticles. Nat. Biotechnol. 23, 741-745 (2005).
18. Storhoff JJ, Lucas AD, Garimella V, Bao YP, Mueller UR: Homogeneous detection of unamplified genomic DNA sequences based on colorimetric scatter of gold nanoparticle probes. Nat. BiotechnoL 22(7), 883-887 (2004).
19. Elghanian R, Storhoff JJ, Mucic RC, Letsinger RL, Mirkin CA: Selective colorimetric detection of polynucleotides based on the distance-dependent optical properties of gold nanoparticles. Science 277(5329). 1078-1080 (1997).
20. Sokolov K, Aaron J, Kumar S et al. Molecular imaging of carcinogenesis with immuno-targeted nanopartides. Proc. 26th Ann. Int. Conf. IEEE EMBS. San Francisco, USA (2004).
21. Sokolov K., Follen M, Aaron J et al.: Realtime vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res. 63, 1999-2004 (2003).
22. Sokolov K, Aaron J, Hse B et al.: Optical systems for in vivo molecular imaging of cancer. Tech. Cancer Res. Treatment 2(6), 491-504 (2003).
23. Averitt RD, Westcott SL, Halas NJ: Linear optical properties of gold nanoshells. J. Opt. Soc. Am. B. 16(10), 1824-1832 (1999).
24. Chen K, Liu Y, Ameer G, Backman V: Optimal design of structured nanospheres for ultrasharp light-scattering resonances as molecular imaging multilabels. J. Biomed Optics 10(2), 024005 (2005).
25. Nehl CL, Grady NK, Goodrich G P, Tam F, Halas NJ, Hafner JH: Scattering spectra of single gold nanoshells. Nana Lett. 4(12), 2355-2359 (2004).
26. Loo C, Lin A, Hirsch L et al.: Nanoshell-enabled photonics-based imaging and therapy of cancer. Tech. Cancer Res. Treatment 3(1), 3340 (2004).
27. Loo C, Lowery A, Halas N, West J, Drezek R: Immunotargeted nanoshells for integrated cancer imaging and therapy. Nano Lett. 5(4), 709-711(2005).
28. O'Neal DO, Hirsch LR, Halas NJ, Payne JD, West JL: Photo-thermal tumor ablation in mice using near infrared-absorbing nanopartides. Cancer Lett. 209, 171-176 (2004).
29. Alivisatos AP: The use of nanocrystals in biological detection. Nat. Biotechnol. 22(1), 47-52 (2004).
30. Chan WCW, Maxwell DJ, Gao X, Bailey RE, Han M, Nie S: Luminescent quantum dots for multiplexed biological detection and imaging. Curr. Opin. Biotech. 13, 40-46 (2002).
31. Michalet X, Pinaud FF, Bentolila LA et al.: Quantum dots for live cells, in vivo imaging, and diagnostics. Science 307, 538-544 (2005).
32. Dahan M, Levi S, Luccardini C, Rostaing P, Riveau B, Triller A: Diffusion dynamics of glycine receptors revealed by single-quantum dot tracking. Science 302, 442-445 (2003).
33. Parak WJ, Boudreau R, Le Gros M et al.: Cell motility and metastatic potential studies based on quantum dot imaging of phagokinetic tracks. Adv. Mater. 14(12), 882-885 (2002).
34. Lidke DS, Nagy P, Heintzmann R et al.: Quantum dot ligands provide new insights into erbB/HER receptor-mediated signal transduction. Nat. Biotechnol. 22, 198-203 (2004).
35. Wu X, Lui H, Lui J et al.: Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nat. Biotechnol 21, 41-46 (2003).
36. Akerman ME, Chan WCW, Laakkonen P, Bhatia SN, Ruoslahti E: Nanocrystal targeting in vivo. Proc. Natl Acad. Sci. USA 99(20), 12617-12621 (2002).
37. Ballou B, Lagerholm BC, Ernst LA, Bruchez MP, Waggoner AS: Noninvasive imaging of quantum dots in mice. Bioconjugate Chem. 15(1), 79-86 (2004).
38. Gao X, Cui Y, Levenson RM, Chung LWK, Nie S: In vivo cancer targeting and imaging with semiconductor quantum dots. Nat. Biotechnol. 22(8), 969-976 (2004).
39. Stroh M, Zimmer JP, Duda DG et al.: Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat. Med. 11(6), 678-682 (2005).
40. Kim S, Lim YT, Soltesz EG et al: Nearinfrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 22(1), 93-97 (2004).
41. Morgan NY, English S, Chen W et al.: Real time in vivo non-invasive optical imaging using near-infrared fluorescent quantum dots. Acad. Rod. 12(3), 314-323 (2005).
42. Choy G, Choyke P, Libutti SK: Current advances in molecular imaging: noninvasive in vivo bioluminescent and fluorescent optical imaging in cancer research. Molec. Imaging 2(4), 302-312 (2003).
43. Weissleder R, Ntziachristos V: Shedding light onto live molecular targets. Nat. Med. 9(1), 123-128 (2003).
44. Mahmood U, Weissleder R: Near-infrared optical imaging of proteases in cancer. Molec. Cancer Therapy 2, 489-496 (2003).
45. Mclntyre JO, Matrisian LM: Molecular imaging of proteolytic activity of cancer, J. Cell. Biochem. 90(Suppl.), 1087-1097 (2003).
46. Marten K, Bremer C, Khazaie K et al.: Detection of dysplastic intestinal adenomas using enzyme sensing molecular beacons in vivo. Gastroenterology 122, 406-414 (2002).
47. Wunderbaldinger P, Turetschck K, Bremer C: Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe. Eur. Radiol. 13, 2206-2211 (2003).
48. Laxman B, Hall DE, Bhojani MS et al.: Noninvasive real-time imaging of apoptosis. Proc. Natl Acad Sci. USA 99, 16551-16555 (2002).
49. Bremer C, Tung CH, Weissleder R: In vivo molecular target assessment of matrix metalloproteinase inhibition. Nat. Med. 7(6), 743-748 (2001).
50. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L: A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 63, 8122-8125(2003).
51. Modo M, Cash D, Mellodew K et al.: Tracking transplanted stem cell migration using bifunctional, contrast agent-enhanced, magnetic resonance imaging. Neurolmage 17, 803-811 (2002).